Literature DB >> 7010075

Prostaglandins as mediators of paraneoplastic syndromes: review and up-date.

S A Metz, J R McRae, R P Robertson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7010075     DOI： 10.1016/0026-0495(81)90156-6

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  8 in total

Review 1.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

Review 2.  Prostaglandins and ulcerative colitis.

Authors:  D S Rampton; C J Hawkey
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

3.  Hypertrophic gastritis associated with increased gastric mucosal prostaglandin E2 concentrations in a patient with the carcinoid syndrome.

Authors:  E J Boyd; G Hulks; J S Thomas; K E McColl
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

4.  Neurological paraneoplastic syndromes.

Authors:  S A Schneck
Journal:  West J Med       Date:  1985-06

Review 5.  Prostaglandins, thromboxanes and leukotrienes in clinical medicine.

Authors:  R D Zipser; G Laffi
Journal:  West J Med       Date:  1985-10

Review 6.  Response of paraneoplastic syndromes to antineoplastic therapy.

Authors:  M Markman
Journal:  West J Med       Date:  1986-05

7.  Bilateral Baker's cyst as the presenting symptom of paraneoplastic syndrome.

Authors:  A Shapira; J Peshin; E Lin; A Gordin; F Mendel; D Herness
Journal:  Arch Orthop Trauma Surg       Date:  1988

8.  Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy.

Authors:  A F Stewart; K L Insogna; D Goltzman; A E Broadus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.